Funding · Company
Axonis Therapeutics, Inc.
Boston, MABiotech & Pharma
Axonis Therapeutics, Inc. of Boston, MA has disclosed $46M across 1 Form D offering filed with the SEC on Nov 1, 2024.
$46M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$46M
Form D · Nov 1, 2024 ↗
Q4 2024
· target $115M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0002043170Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →